latanoprost (Xalatan)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Xalatan.

Indications

Contraindications

pregnancy-category :value C

safety-in-lactation :value ?

Dosage

Solution: (ophthalmic) 0.005% (2.5 mL) (contains benzalkonium chloride).

Storage

Adverse effects

Drug interactions

Mechanism of action

More general terms

Additional terms

Component of

Components

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998 - not on National VA formulary
  3. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  4. 4.0 4.1 Prescriber's Letter 8(5):28 2001
  5. Prescriber's Letter 10(2):10 2003
  6. 6.0 6.1 Bausch and Lomb. Package insert
  7. 7.0 7.1 Garway-Heath DF et al Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. Dec 19, 2014 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2962111-5/abstract

Database